Net income available to common shareholders for Q4 2025 was $84.8 million, a substantial increase from $0.9 million in Q4 2024. Full year 2025 net income available to common shareholders reached $299.4 million, a significant recovery from a net loss of $(772.3) million in full year 2024. Adjusted EBITDA for Q4 2025 was $104.2 million, up from $(113.8) million in Q4 2024, and for the full year 2025 was $231.1 million, compared to $(568.3) million in full year 2024. Total revenues for Q4 2025 increased to $278.4 million from $178.6 million in Q4 2024, and for the full year 2025 rose to $967.6 million from $746.4 million in full year 2024. Total debt was reduced by $346.6 million to $1.43 billion at December 31, 2025, primarily through senior note exchanges, redemptions, term loan repayments, and asset sales. Net Debt declined by $436.7 million in full year 2025 to $627.0 million at December 31, 2025. The company regained compliance with Nasdaq's Periodic Filing Rule in January 2026 after filing three 2025 10-Qs between November 2025 and January 2026. Basic and diluted EPS for full year 2025 was $9.80, a significant improvement from $(25.46) in full year 2024.